Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy
Breast cancer is the most prevalent type of cancer among women. Several types of drugs, targeting the specific proteins expressed on the breast cancer cell surface (such as receptor tyrosine kinases and immune checkpoint regulators) and proteins involved in cell cycle and motility (including cyclin-...
Saved in:
Main Authors: | Kaboli, Parham Jabbarzadeh, Imani, Saber, Jomhori, Masume, Ling, King Hwa |
---|---|
Format: | Article |
Published: |
e-Century Publishing
2021
|
Online Access: | http://psasir.upm.edu.my/id/eprint/96382/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569340/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular modelling of berberine derivatives as inhibitors of oncogenic signalling pathways in breast cancer cell lines
by: Kaboli, Parham Jabbarzadeh
Published: (2017) -
Targets and mechanisms of berberine,a natural drug with potential to treat cancer with special focus on breast cancer
by: Kaboli, Parham Jabbarzadeh, et al.
Published: (2014) -
MicroRNA-based therapy and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment
by: Rahmat, Asmah, et al.
Published: (2015) -
Matrix metalloproteinases in chemoresistance: regulatory roles, molecular interactions, and potential inhibitors
by: Xin, Bernadette Jie Tune, et al.
Published: (2022) -
Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors
by: Tune, Bernadette Xin Jie, et al.
Published: (2022)